Novel Non-Coding Transcript in NR4A3 Locus, LncNR4A3, Regulates RNA Processing Machinery Proteins and NR4A3 Expression
is a key tumor suppressor in myeloid malignancy, mice lacking both and family member rapidly develop lethal acute myeloid leukemia (AML). We identified a long non-coding transcript in the locus and pursued the characterization of this anonymous transcript and the study of its role in leukemogenesis....
Saved in:
Published in: | Frontiers in oncology Vol. 10; p. 569668 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
23-11-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | is a key tumor suppressor in myeloid malignancy, mice lacking both
and family member
rapidly develop lethal acute myeloid leukemia (AML). We identified a long non-coding transcript in the
locus and pursued the characterization of this anonymous transcript and the study of its role in leukemogenesis. We characterized this novel long non-coding transcript as a sense polyadenylated transcript. Bone marrow cells from AML patients expressed significantly reduced levels of lncNR4A3 compared to healthy controls (controls = 15, MDS= 20, p=0.05., AML= 21, p<0.01). Expression of
, as previously reported, was also significantly reduced in AML. Interestingly, the expression of both coding and non-coding transcripts was highly correlated (Pearson R = 0.3771, P<0.01). Transient over-expression of LncNR4A3 by nucleofection led to an increase in the RNA and protein level of
, reduction of proliferation in myeloid cell lines K-562 and KG1 (n=3 and 2 respectively, p<0.05) and reduced colony formation capacity in primary leukemic cells. A mass spectrometry-based quantitative proteomics approach was used to identify proteins dysregulated after lncNR4A3 over-expression in K-562. Enrichment analysis showed that the altered proteins are biologically connected (n=4, p<0.001) and functionally associated to RNA binding, transcription elongation, and splicing. Remarkably, we were able to validate the most significant results by WB. We showed that this novel transcript, lncNR4A3 regulates
and we hypothesize this regulatory mechanism is mediated by the modulation of the RNA processing machinery. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Jawed Akhtar Siddiqui, University of Nebraska Medical Center, United States Reviewed by: Alexander Deutsch, Medical University of Graz, Austria; Jian Pan, Soochow University, China; Shenglai Li, University of Chicago, United States This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2020.569668 |